JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL) — 分析摘要
JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares(ZJYL)的市值为173.11百万美元,最近一年的营收同比增长了-12.0%。净利润率为5.8%。当前市盈率为145.3倍。
核心要点
- 营收同比变化-12.0%
- 净利润率5.8%
- 市盈率145.3倍
ZJYL的营收增长为-12.0%,市盈率为145.3倍。
JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL)
更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗,在依赖任何估值输出前应先重点核查这些风险。
Debt/EBITDA 为 22.1x — 高杠杆,存在再融资风险
最新报表显示自由现金流为负。
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
员工人数
273
Exchange
XNAS
基于 3 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。